[Organic mixed affective disorder].
Sasaki M.
Ryoikibetsu Shokogun Shirizu. 2003;(40):180-3.
Depressive Cognitive Disorders.
Sekhon S, Marwaha R.
2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Pseudodementia.
Fisman M.
Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):481-4. doi: 10.1016/0278-5846(85)90005-3.
[Diagnostics and early recognition of bipolar disorders].
Schäfer M, Correll CU.
Nervenarzt. 2020 Mar;91(3):207-215. doi: 10.1007/s00115-020-00881-5.
Exposure to environmental chemicals and perinatal psychopathology.
Jacobson MH, Ghassabian A, Gore AC, Trasande L.
Biochem Pharmacol. 2022 Jan;195:114835. doi: 10.1016/j.bcp.2021.114835. Epub 2021 Nov 11.
[Fluvoxamine in the treatment of anxiety-depressive spectrum disorders].
Medvedev VE, Kardashian RA, Frolova VI.
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(6):101-109. doi: 10.17116/jnevro2024124061101.
Gut-brain axis volatile organic compounds derived from breath distinguish between schizophrenia and major depressive disorder.
Henning D, Lüno M, Jiang C, Meyer-Lotz G, Hoeschen C, Frodl T.
J Psychiatry Neurosci. 2023 Apr 12;48(2):E117-E125. doi: 10.1503/jpn.220139. Print 2023 Mar-Apr.
Mixed bipolar disorder precipitated by pseudoephedrine hydrochloride.
Dalton R.
South Med J. 1990 Jan;83(1):64-5. doi: 10.1097/00007611-199001000-00020.
Mixed organic brain syndrome as a manifestation of systemic mastocytosis.
Rogers MP, Bloomingdale K, Murawski BJ, Soter NA, Reich P, Austen KF.
Psychosom Med. 1986 Jul-Aug;48(6):437-47. doi: 10.1097/00006842-198607000-00006.
Clotiapine for acute psychotic illnesses.
Carpenter S, Berk M.
Cochrane Database Syst Rev. 2001;(1):CD002304. doi: 10.1002/14651858.CD002304.
